Skip to main content

. 1990 Apr;61(4):495–496. doi: 10.1038/bjc.1990.111

An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.

PMCID: PMC1971350 PMID: 2184877

495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Begg C. B., Berlin J. A. Publication bias and dissemination of clinical research. J Natl Cancer Inst. 1989 Jan 18;81(2):107–115. doi: 10.1093/jnci/81.2.107. [DOI] [PubMed] [Google Scholar]
Brodovsky H. S., Bauer M., Horton J., Elson P. J. Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer. Cancer. 1984 Feb 15;53(4):844–852. doi: 10.1002/1097-0142(19840215)53:4<844::aid-cncr2820530405>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
Cody M. M., Slevin M. L. Treatment decisions in advanced ovarian cancer. Br J Cancer. 1989 Aug;60(2):155–156. doi: 10.1038/bjc.1989.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
Griffiths C. T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct;42:101–104. [PubMed] [Google Scholar]
Simes R. J. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986 Oct;4(10):1529–1541. doi: 10.1200/JCO.1986.4.10.1529. [DOI] [PubMed] [Google Scholar]
Young R. C., Chabner B. A., Hubbard S. P., Fisher R. I., Bender R. A., Anderson T., Simon R. M., Canellos G. P., DeVita V. T., Jr Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 Dec 7;299(23):1261–1266. doi: 10.1056/NEJM197812072992301. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES